Filgrastim Injection is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Filgrastim injection is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications. Filgrastim injection is also used in people who are undergoing bone marrow transplants, in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood), and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body. Filgrastim injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to the bone marrow. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.
This report aims to provide a comprehensive presentation of the global market for Filgrastim Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filgrastim Injection. This report contains market size and forecasts of Filgrastim Injection in global, including the following market information:
Global Filgrastim Injection Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Filgrastim Injection Market Sales, 2018-2023, 2024-2032, (KL)
Global top five Filgrastim Injection companies in 2022 (%)
The global Filgrastim Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
300mcg/mL (vial) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Filgrastim Injection include Accord Healthcare, Teva Pharmaceuticals, Pfizer, Amgen Inc and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Filgrastim Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Filgrastim Injection Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (KL)
Global Filgrastim Injection Market Segment Percentages, by Type, 2022 (%)
300mcg/mL (vial)
480mcg/1.6 mL (vial)
300mcg/0.5mL (Prefilled Syringe)
480mcg/0.8mL (Prefilled Syringe)
Global Filgrastim Injection Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (KL)
Global Filgrastim Injection Market Segment Percentages, by Application, 2022 (%)
Adult Use
Pediatric Use
Geriatric Use
Global Filgrastim Injection Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (KL)
Global Filgrastim Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Filgrastim Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Filgrastim Injection revenues share in global market, 2022 (%)
Key companies Filgrastim Injection sales in global market, 2018-2023 (Estimated), (KL)
Key companies Filgrastim Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Accord Healthcare
Teva Pharmaceuticals
Pfizer
Amgen Inc
Novartis AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Filgrastim Injection, market overview.
Chapter 2: Global Filgrastim Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Filgrastim Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Filgrastim Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Filgrastim Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Filgrastim Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Filgrastim Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Filgrastim Injection Overall Market Size
2.1 Global Filgrastim Injection Market Size: 2022 VS 2032
2.2 Global Filgrastim Injection Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Filgrastim Injection Sales: 2018-2032
3 Company Landscape
3.1 Top Filgrastim Injection Players in Global Market
3.2 Top Global Filgrastim Injection Companies Ranked by Revenue
3.3 Global Filgrastim Injection Revenue by Companies
3.4 Global Filgrastim Injection Sales by Companies
3.5 Global Filgrastim Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Filgrastim Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Filgrastim Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Filgrastim Injection Players in Global Market
3.8.1 List of Global Tier 1 Filgrastim Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Filgrastim Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Filgrastim Injection Market Size Markets, 2022 & 2032
4.1.2 300mcg/mL (vial)
4.1.3 480mcg/1.6 mL (vial)
4.1.4 300mcg/0.5mL (Prefilled Syringe)
4.1.5 480mcg/0.8mL (Prefilled Syringe)
4.2 By Type - Global Filgrastim Injection Revenue & Forecasts
4.2.1 By Type - Global Filgrastim Injection Revenue, 2018-2023
4.2.2 By Type - Global Filgrastim Injection Revenue, 2024-2032
4.2.3 By Type - Global Filgrastim Injection Revenue Market Share, 2018-2032
4.3 By Type - Global Filgrastim Injection Sales & Forecasts
4.3.1 By Type - Global Filgrastim Injection Sales, 2018-2023
4.3.2 By Type - Global Filgrastim Injection Sales, 2024-2032
4.3.3 By Type - Global Filgrastim Injection Sales Market Share, 2018-2032
4.4 By Type - Global Filgrastim Injection Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Filgrastim Injection Market Size, 2022 & 2032
5.1.2 Adult Use
5.1.3 Pediatric Use
5.1.4 Geriatric Use
5.2 By Application - Global Filgrastim Injection Revenue & Forecasts
5.2.1 By Application - Global Filgrastim Injection Revenue, 2018-2023
5.2.2 By Application - Global Filgrastim Injection Revenue, 2024-2032
5.2.3 By Application - Global Filgrastim Injection Revenue Market Share, 2018-2032
5.3 By Application - Global Filgrastim Injection Sales & Forecasts
5.3.1 By Application - Global Filgrastim Injection Sales, 2018-2023
5.3.2 By Application - Global Filgrastim Injection Sales, 2024-2032
5.3.3 By Application - Global Filgrastim Injection Sales Market Share, 2018-2032
5.4 By Application - Global Filgrastim Injection Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Filgrastim Injection Market Size, 2022 & 2032
6.2 By Region - Global Filgrastim Injection Revenue & Forecasts
6.2.1 By Region - Global Filgrastim Injection Revenue, 2018-2023
6.2.2 By Region - Global Filgrastim Injection Revenue, 2024-2032
6.2.3 By Region - Global Filgrastim Injection Revenue Market Share, 2018-2032
6.3 By Region - Global Filgrastim Injection Sales & Forecasts
6.3.1 By Region - Global Filgrastim Injection Sales, 2018-2023
6.3.2 By Region - Global Filgrastim Injection Sales, 2024-2032
6.3.3 By Region - Global Filgrastim Injection Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Filgrastim Injection Revenue, 2018-2032
6.4.2 By Country - North America Filgrastim Injection Sales, 2018-2032
6.4.3 US Filgrastim Injection Market Size, 2018-2032
6.4.4 Canada Filgrastim Injection Market Size, 2018-2032
6.4.5 Mexico Filgrastim Injection Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Filgrastim Injection Revenue, 2018-2032
6.5.2 By Country - Europe Filgrastim Injection Sales, 2018-2032
6.5.3 Germany Filgrastim Injection Market Size, 2018-2032
6.5.4 France Filgrastim Injection Market Size, 2018-2032
6.5.5 U.K. Filgrastim Injection Market Size, 2018-2032
6.5.6 Italy Filgrastim Injection Market Size, 2018-2032
6.5.7 Russia Filgrastim Injection Market Size, 2018-2032
6.5.8 Nordic Countries Filgrastim Injection Market Size, 2018-2032
6.5.9 Benelux Filgrastim Injection Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Filgrastim Injection Revenue, 2018-2032
6.6.2 By Region - Asia Filgrastim Injection Sales, 2018-2032
6.6.3 China Filgrastim Injection Market Size, 2018-2032
6.6.4 Japan Filgrastim Injection Market Size, 2018-2032
6.6.5 South Korea Filgrastim Injection Market Size, 2018-2032
6.6.6 Southeast Asia Filgrastim Injection Market Size, 2018-2032
6.6.7 India Filgrastim Injection Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Filgrastim Injection Revenue, 2018-2032
6.7.2 By Country - South America Filgrastim Injection Sales, 2018-2032
6.7.3 Brazil Filgrastim Injection Market Size, 2018-2032
6.7.4 Argentina Filgrastim Injection Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Filgrastim Injection Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Filgrastim Injection Sales, 2018-2032
6.8.3 Turkey Filgrastim Injection Market Size, 2018-2032
6.8.4 Israel Filgrastim Injection Market Size, 2018-2032
6.8.5 Saudi Arabia Filgrastim Injection Market Size, 2018-2032
6.8.6 UAE Filgrastim Injection Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Accord Healthcare
7.1.1 Accord Healthcare Company Summary
7.1.2 Accord Healthcare Business Overview
7.1.3 Accord Healthcare Filgrastim Injection Major Product Offerings
7.1.4 Accord Healthcare Filgrastim Injection Sales and Revenue in Global (2018-2023)
7.1.5 Accord Healthcare Key News & Latest Developments
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Company Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Filgrastim Injection Major Product Offerings
7.2.4 Teva Pharmaceuticals Filgrastim Injection Sales and Revenue in Global (2018-2023)
7.2.5 Teva Pharmaceuticals Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Filgrastim Injection Major Product Offerings
7.3.4 Pfizer Filgrastim Injection Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Amgen Inc
7.4.1 Amgen Inc Company Summary
7.4.2 Amgen Inc Business Overview
7.4.3 Amgen Inc Filgrastim Injection Major Product Offerings
7.4.4 Amgen Inc Filgrastim Injection Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Inc Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Filgrastim Injection Major Product Offerings
7.5.4 Novartis AG Filgrastim Injection Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
8 Global Filgrastim Injection Production Capacity, Analysis
8.1 Global Filgrastim Injection Production Capacity, 2018-2032
8.2 Filgrastim Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Filgrastim Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Filgrastim Injection Supply Chain Analysis
10.1 Filgrastim Injection Industry Value Chain
10.2 Filgrastim Injection Upstream Market
10.3 Filgrastim Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Filgrastim Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Filgrastim Injection in Global Market
Table 2. Top Filgrastim Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Filgrastim Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Filgrastim Injection Revenue Share by Companies, 2018-2023
Table 5. Global Filgrastim Injection Sales by Companies, (KL), 2018-2023
Table 6. Global Filgrastim Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Filgrastim Injection Price (2018-2023) & (US$/L)
Table 8. Global Manufacturers Filgrastim Injection Product Type
Table 9. List of Global Tier 1 Filgrastim Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Filgrastim Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Filgrastim Injection Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Filgrastim Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Filgrastim Injection Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Filgrastim Injection Sales (KL), 2018-2023
Table 15. By Type - Global Filgrastim Injection Sales (KL), 2024-2032
Table 16. By Application ? Global Filgrastim Injection Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Filgrastim Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Filgrastim Injection Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Filgrastim Injection Sales (KL), 2018-2023
Table 20. By Application - Global Filgrastim Injection Sales (KL), 2024-2032
Table 21. By Region ? Global Filgrastim Injection Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Filgrastim Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Filgrastim Injection Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Filgrastim Injection Sales (KL), 2018-2023
Table 25. By Region - Global Filgrastim Injection Sales (KL), 2024-2032
Table 26. By Country - North America Filgrastim Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Filgrastim Injection Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Filgrastim Injection Sales, (KL), 2018-2023
Table 29. By Country - North America Filgrastim Injection Sales, (KL), 2024-2032
Table 30. By Country - Europe Filgrastim Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Filgrastim Injection Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Filgrastim Injection Sales, (KL), 2018-2023
Table 33. By Country - Europe Filgrastim Injection Sales, (KL), 2024-2032
Table 34. By Region - Asia Filgrastim Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Filgrastim Injection Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Filgrastim Injection Sales, (KL), 2018-2023
Table 37. By Region - Asia Filgrastim Injection Sales, (KL), 2024-2032
Table 38. By Country - South America Filgrastim Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Filgrastim Injection Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Filgrastim Injection Sales, (KL), 2018-2023
Table 41. By Country - South America Filgrastim Injection Sales, (KL), 2024-2032
Table 42. By Country - Middle East & Africa Filgrastim Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Filgrastim Injection Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Filgrastim Injection Sales, (KL), 2018-2023
Table 45. By Country - Middle East & Africa Filgrastim Injection Sales, (KL), 2024-2032
Table 46. Accord Healthcare Company Summary
Table 47. Accord Healthcare Filgrastim Injection Product Offerings
Table 48. Accord Healthcare Filgrastim Injection Sales (KL), Revenue (US$, Mn) and Average Price (US$/L) (2018-2023)
Table 49. Accord Healthcare Key News & Latest Developments
Table 50. Teva Pharmaceuticals Company Summary
Table 51. Teva Pharmaceuticals Filgrastim Injection Product Offerings
Table 52. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue (US$, Mn) and Average Price (US$/L) (2018-2023)
Table 53. Teva Pharmaceuticals Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Filgrastim Injection Product Offerings
Table 56. Pfizer Filgrastim Injection Sales (KL), Revenue (US$, Mn) and Average Price (US$/L) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Amgen Inc Company Summary
Table 59. Amgen Inc Filgrastim Injection Product Offerings
Table 60. Amgen Inc Filgrastim Injection Sales (KL), Revenue (US$, Mn) and Average Price (US$/L) (2018-2023)
Table 61. Amgen Inc Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Filgrastim Injection Product Offerings
Table 64. Novartis AG Filgrastim Injection Sales (KL), Revenue (US$, Mn) and Average Price (US$/L) (2018-2023)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Filgrastim Injection Production Capacity (KL) of Key Manufacturers in Global Market, 2021-2023 (KL)
Table 67. Global Filgrastim Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Filgrastim Injection Production by Region, 2018-2023 (KL)
Table 69. Global Filgrastim Injection Production by Region, 2024-2032 (KL)
Table 70. Filgrastim Injection Market Opportunities & Trends in Global Market
Table 71. Filgrastim Injection Market Drivers in Global Market
Table 72. Filgrastim Injection Market Restraints in Global Market
Table 73. Filgrastim Injection Raw Materials
Table 74. Filgrastim Injection Raw Materials Suppliers in Global Market
Table 75. Typical Filgrastim Injection Downstream
Table 76. Filgrastim Injection Downstream Clients in Global Market
Table 77. Filgrastim Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Filgrastim Injection Segment by Type in 2022
Figure 2. Filgrastim Injection Segment by Application in 2022
Figure 3. Global Filgrastim Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Filgrastim Injection Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Filgrastim Injection Revenue, 2018-2032 (US$, Mn)
Figure 7. Filgrastim Injection Sales in Global Market: 2018-2032 (KL)
Figure 8. The Top 3 and 5 Players Market Share by Filgrastim Injection Revenue in 2022
Figure 9. By Type - Global Filgrastim Injection Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Filgrastim Injection Revenue Market Share, 2018-2032
Figure 11. By Type - Global Filgrastim Injection Sales Market Share, 2018-2032
Figure 12. By Type - Global Filgrastim Injection Price (US$/L), 2018-2032
Figure 13. By Application - Global Filgrastim Injection Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Filgrastim Injection Revenue Market Share, 2018-2032
Figure 15. By Application - Global Filgrastim Injection Sales Market Share, 2018-2032
Figure 16. By Application - Global Filgrastim Injection Price (US$/L), 2018-2032
Figure 17. By Region - Global Filgrastim Injection Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Filgrastim Injection Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Filgrastim Injection Revenue Market Share, 2018-2032
Figure 20. By Region - Global Filgrastim Injection Sales Market Share, 2018-2032
Figure 21. By Country - North America Filgrastim Injection Revenue Market Share, 2018-2032
Figure 22. By Country - North America Filgrastim Injection Sales Market Share, 2018-2032
Figure 23. US Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Filgrastim Injection Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Filgrastim Injection Sales Market Share, 2018-2032
Figure 28. Germany Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 29. France Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Filgrastim Injection Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Filgrastim Injection Sales Market Share, 2018-2032
Figure 37. China Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 41. India Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Filgrastim Injection Revenue Market Share, 2018-2032
Figure 43. By Country - South America Filgrastim Injection Sales Market Share, 2018-2032
Figure 44. Brazil Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Filgrastim Injection Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Filgrastim Injection Sales Market Share, 2018-2032
Figure 48. Turkey Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Filgrastim Injection Revenue, (US$, Mn), 2018-2032
Figure 52. Global Filgrastim Injection Production Capacity (KL), 2018-2032
Figure 53. The Percentage of Production Filgrastim Injection by Region, 2022 VS 2032
Figure 54. Filgrastim Injection Industry Value Chain
Figure 55. Marketing Channels
